Showing 131-140 of 2672 results for "".
New in My Practice: Device
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-device/23900/2015 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2015-fourth-quarter-tax-saving-tips/21088/What to do now to save $10,000-$25,000 or more on your 2015 taxes.2014 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2014-fourth-quarter-tax-saving-tips/21294/What to do now to save $10,000-$25,000 or more on your 2014 taxes.Market Your Dermatology Practice with Infographics
https://practicaldermatology.com/topics/practice-management/market-your-dermatology-practice-with-infographics/23075/Don’t just show or tell. Do both!Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/topics/rare-disease/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/39997/DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.Soliton’s RAP Technology for Cellulite
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/solitons-rap-technology-for-cellulite/23465/An inside look at the latest device designed to target cellulite.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/20326/